Refractory Ascites in Children With Cirrhosis

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Refractory Ascites in Children With Cirrhosis trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 1

NCT05490888

Single and Multiple Dose Escalation of PHIN-214 in Child-Pugh A and B Liver Cirrhotics

This 2-part study will evaluate PHIN-214 given as a single one-time dose (Part 1) and in multiple doses (given as daily doses for 28-days) (in Part 2). Specific…

United States74 participantsStarted 2022-01-03

Treatment: PHIN-214 Subcutaneous injection

All recent trials (3 shown)

WithdrawnNot Applicable

NCT05084534

Efficacy and Safety of Midodrine in Refractory or Recurrent Ascites in Children With Cirrhosis.

Refractory ascites is seen in 17% of cirrhotic patients with the 1year mortality rate being high, upto 20-50% \[1\]. The pathogenesis of cirrhotic ascites inclu…

India0Started 2021-11-01

Treatment: Midodrine, Standard medical treatment

UnknownPhase 3

NCT01854125

Autologous Mesenchymal Stem Cell Transplantation in Cirrhosis Patients With Refractory Ascites

Liver cirrhosis (LC) is the final destiny in chronic liver disease.The quality of life in liver cirrhosis patients with refractory ascites are very wretched. Th…

China30 participantsStarted 2013-05

Treatment: autologous bone marrow mesenchymal stem cells transplantation, autologous bone marrow msenchymal stem cells transplantation